Researchers at the Institute of Nano Science and Technology in India have introduced a groundbreaking treatment for Alzheimer’s disease. This new therapy, reported by IANS in collaboration with TV BRICS, uses advanced nanoparticles to tackle the disease from multiple angles.
Unlike traditional Alzheimer’s treatments that focus on only one aspect of the disease, this innovative approach addresses several underlying causes of Alzheimer’s simultaneously.
The treatment is based on nanoparticles that combine green tea polyphenols, a neurotransmitter, and an amino acid. These particles work by targeting amyloid aggregation, which is a hallmark of Alzheimer’s, while also reducing oxidative stress, easing inflammation, and preventing damage to brain cells.
These nanoparticles are created through eco-friendly and biocompatible methods, including hydrothermal treatment and electrostatic incubation, making them safer and more efficient for human use.
The study marks an important step forward, as it doesn’t just remove plaques associated with Alzheimer’s, but also reduces stress in the brain, lowers inflammation, and encourages the growth of nerve cells.
The development of this treatment highlights the active role of BRICS countries in finding new ways to treat Alzheimer’s. Brazilian scientists, for instance, are making significant strides by using blood tests to detect Alzheimer’s early. By testing for the tau217 protein, they can now diagnose the disease more effectively.
Meanwhile, in Russia, researchers at Peter the Great St. Petersburg Polytechnic University have developed nanoparticles to treat melanoma, while Chinese scientists have proposed a blood test to detect osteoporosis, offering promising solutions to different health challenges.
This research signals hope for more effective and comprehensive treatments for Alzheimer’s and other age-related diseases, opening the door to new approaches in healthcare.
Related topic：
